Results 281 to 290 of about 435,985 (359)

Clinical backgrounds and outcomes of patients with Barrett's esophageal adenocarcinoma treated via endoscopic submucosal dissection in Kyushu, Japan: A retrospective multicenter cohort study

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract Objectives Most esophageal cancers in Japan are squamous cell carcinomas; however, there has been some concern regarding a recent increase in Barrett's esophageal adenocarcinoma (BEA). This study aimed to clarify the clinical characteristics and outcomes of patients treated via endoscopic submucosal dissection (ESD) in Kyushu, including ...
Fumisato Sasaki   +29 more
wiley   +1 more source

Diagnosis and treatment of gastric abscess by endoscopic ultrasound: A mini‐review of the preliminary application

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract Gastric abscess is a rare condition caused by gastric barrier damage. It is easily misdiagnosed in clinical practice as a cancer recurrence or submucosal tumor, especially after surgery or endoscopic submucosal dissection. With a relatively high mortality rate, the cause and clinical characteristics of gastric abscesses are obscure.
Jia Xie, Mo‐Jin Wang, Rui Wang
wiley   +1 more source

A pilot study on anti‐reflux mucoplasty with valve as novel endoscopic therapy for gastroesophageal reflux disease

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract Background and aims Endoscopic anti‐reflux therapies like anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation have shown efficacy for gastroesophageal reflux disease (GERD) in systematic reviews and meta‐analyses. Anti‐reflux mucoplasty (ARM‐P), a refinement of ARMS, incorporates immediate closure of the resection site to reduce ...
Kazuki Yamamoto   +11 more
wiley   +1 more source

Clinical Characteristics and Outcomes of Incomplete Cardia Reconstruction Cases Following Multiple Anti‐reflux Mucosectomy/Anti‐reflux Mucosal Ablation Treatments

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Introduction Anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation (ARMA) are novel endoscopic treatments for proton pump inhibitor or potassium‐competitive acid blocker‐refractory gastroesophageal reflux disease. These procedures induce scarring of the artificial ulcer at the gastric cardia, which tightens the enlarged cardiac ...
Ippei Tanaka   +8 more
wiley   +1 more source

The association of the activation-inducible tumor necrosis factor receptor and ligand with lumbar disc hermiation [PDF]

open access: yes, 2007
Hahn, Soo-Bong   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy